Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 31, 2025 07:57 ET | Source: Research and Markets

Cancer Cachexia Market Trends and Growth Outlook (2025-2035) by Therapy Type, Stage of Cachexia, Distribution Channel and Region

Dublin, Oct. 31, 2025 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - A Global and Regional Analysis: Focus on Therapy Type, Stage of Cachexia, Distribution Channel, and Region - Analysis and...
May 20, 2025 03:00 ET | Source: Actimed Therapeutics

Actimed Therapeutics Announces New Programme to Investigate Potential Muscle Preservation Effects of S-pindolol Benzoate in Obese Patients Treated with GLP-1 Agonists

Two-part preclincal and clinical development programme launched to assess potential benefits of administering S-pindolol benzoate during and post-GLP-1 receptor agonist therapy to improve muscle mass,...
August 23, 2024 11:51 ET | Source: Research and Markets

Cancer Cachexia Market Forecasted to Reach $3.14 Billion by 2028 with a CAGR of 6.2% - Long-term Forecast to 2033

Dublin, Aug. 23, 2024 (GLOBE NEWSWIRE) -- The "Global Cancer Cachexia Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global cancer cachexia market is forecast to...
May 03, 2024 04:30 ET | Source: Custom Market Insights

[Latest] Global Cancer Cachexia Market Size/Share Worth USD 5.1 Billion by 2033 at a 5.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)

Austin, TX, USA, May 03, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Cancer Cachexia Market Size, Trends and Insights By Therapeutics (Progestogen,...
April 11, 2024 04:23 ET | Source: Research and Markets

Global Clinical Nutrition For Cancer Care Report 2024-2030, by Product (Oral, Nutrition Enteral Feeding Formulas, Parenteral Nutrition), Stage, Sales Channel, Region and Segment Forecasts

Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Clinical Nutrition For Cancer Care Market Size, Share & Trends Analysis Report by Product (Oral, Nutrition Enteral Feeding Formulas,...
April 05, 2024 09:27 ET | Source: Research and Markets

Cancer Cachexia Global Strategic Research Report 2024: Market to Reach $3.5 Billion by 2030, Driven by Promising Treatment Options

Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Global Cancer Cachexia Market to Reach...
March 20, 2024 11:13 ET | Source: Research and Markets

Global Cancer Cachexia Market Worth $2.85 Billion by 2029: Combination Therapies Gaining Traction

Dublin, March 20, 2024 (GLOBE NEWSWIRE) -- The "Cancer Cachexia Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. This research report sheds light...
October 19, 2023 03:00 ET | Source: Actimed Therapeutics

Actimed Therapeutics Appoints Martin Walton as Chief Financial Officer

London, UK – 19th October 2023. Actimed Therapeutics Ltd (“Actimed”), a UK based clinical stage specialty pharmaceutical company focused on bringing innovation to the treatment of cancer cachexia and...
February 13, 2017 06:00 ET | Source: India Globalization Capital

IGC Launches Phytocannabinoid Development Committee to Secure Preclinical Initiatives for IGC-501, IGC-502 and IGC-504

BETHESDA, Md., Feb. 13, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE-MKT:IGC) announces today that its Phytocannabinoid Development Committee has started its review of...
November 02, 2016 09:32 ET | Source: India Globalization Capital

IGC Provides Update on Phytocannabinoid IP Portfolio

BETHESDA, Md., Nov. 02, 2016 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE MKT:IGC) announces updates for five patents related to method and treatment of pain, seizures and eating...